Abstract
Objectives
We herein review the outcomes of paediatric lung transplantation (LTx) and analyse subgroups divided by age.
Methods
We retrospectively reviewed 43 consecutive paediatric LTx recipients (< 18 years old: cadaveric LTx [n = 9], living-donor lobar LTx [n = 34]). We also analysed subgroups of patients 1–6 years old (n = 10) and 7–17 years old (n = 33).
Results
The 1-, 5- and 10-year overall survival (OS) rates in paediatric recipients were 93%, 82% and 67%, respectively. The 1-, 5- and 10-year graft dysfunction (GD)-free survival rates in paediatric recipients were 85%, 59% and 31%, respectively. The 1- and 5-year OS in the 1- to 6-year-old vs. 7- to 17-year-old groups were 70% vs. 100% and 48% vs. 93%, respectively (p < 0.0001). The 1- and 5-year GD-free survival rates in the 1- to 6-year-old vs. 7- to 17-year-old groups were 60% vs. 93% and 24% vs. 69%, respectively (p = 0.024). The 1- to 6-year-old group showed higher rates of non-standard LTx (p = 0.0001), interstitial pneumonia (p = 0.004) and ventilator dependency (p = 0.007) than the 7- to 17-year-old group.
Conclusion
Paediatric recipients under 7 years old seemed to have a higher risk of mortality and GD than those 7 years old and older.
Similar content being viewed by others
Abbreviations
- AMR:
-
Antibody-mediated rejection
- CLAD:
-
Chronic lung allograft dysfunction
- CLTx:
-
Cadaveric lung transplantation
- FVC:
-
Forced vital capacity
- GD:
-
Lung graft dysfunction
- ISHLT:
-
International Society for Heart and Lung Transplantation
- LAS:
-
Lung allocation score
- LDLLTx:
-
Living-donor lobar lung transplantation
- LTx:
-
Lung transplantation
- OS:
-
Overall survival
References
Mendeloff EN. The history of pediatric heart and lung transplantation. Pediatr Transplant. 2002;6(4):270–9.
Hayes D Jr, Cherikh WS, Chambers DC, Harhay MO, Khush KK, Lehman RR, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric lung and heart-lung transplantation report-2019; Focus theme: Donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1015–27.
Date H, Aoe M, Nagahiro I, Sano Y, Andou A, Matsubara H, et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg. 2003;126(2):476–81.
Date H, Sato M, Aoyama A, Yamada T, Mizota T, Kinoshita H, et al. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patientsdagger. Eur J Cardiothorac Surg. 2015;47(6):967–72 (discussion 72-3).
Hoshikawa Y, Okada Y, Ashikari J, Matsuda Y, Niikawa H, Noda M, et al. Medical consultant system for improving lung transplantation opportunities and outcomes in Japan. Transplant Proc. 2015;47(3):746–50.
Otani S, Oto T, Miyoshi S. Living-donor lobar lung retransplantation for an adult patient with bronchiolitis obliterans syndrome: an option for retransplantation. J Heart Lung Transplant. 2013;32(4):469–70.
Kurosaki T, Miyoshi K, Otani S, Imanishi K, Sugimoto S, Yamane M, et al. Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients. Surg Today. 2018;48(10):928–35.
Otani S, Kurosaki T, Sugimoto S, Yamane M, Oto T. Unilateral lung transplantation using intact bilateral upper lobes. J Thorac Cardiovasc Surg. 2018;156(1):e35–8.
Yamamoto H, Miyoshi K, Otani S, Kurosaki T, Sugimoto S, Yamane M, et al. Right single lung transplantation using an inverted left donor lung: interposition of pericardial conduit for pulmonary venous anastomosis—a case report. BMC Pulm Med. 2020;20(1):46.
Kurosaki T, Oto T, Otani S, Miyoshi K, Sugimoto S, Yamane M, et al. "Hybrid Lung Transplantation" combining living donor and cadaveric lung transplants: report of 2 Cases. Transplant Proc. 2021;53(6):2004–7.
Oto T, Miyoshi K, Sugimoto S, Yamane M. Living related donor middle lobe lung transplant in a pediatric patient. J Thorac Cardiovasc Surg. 2015;149(3):e42–4.
Oto T, Hikasa Y, Hagiyama A, Kobayashi M. Bilateral segmental lung transplantation for children: transplantation using split adult living-donor lower lobe. J Thorac Cardiovasc Surg Tech. 2020;3:311–4.
Oto T, Levvey BJ, Whitford H, Griffiths AP, Kotsimbos T, Williams TJ, et al. Feasibility and utility of a lung donor score: correlation with early post-transplant outcomes. Ann Thorac Surg. 2007;83(1):257–63.
Goldstein BS, Sweet SC, Mao J, Huddleston CB, Grady RM. Lung transplantation in children with idiopathic pulmonary arterial hypertension: an 18-year experience. J Heart Lung Transplant. 2011;30(10):1148–52.
Gorler H, Struber M, Ballmann M, Muller C, Gottlieb J, Warnecke G, et al. Lung and heart-lung transplantation in children and adolescents: a long-term single-center experience. J Heart Lung Transplant. 2009;28(3):243–8.
Khan MS, Zhang W, Taylor RA, Dean McKenzie E, Mallory GB, Schecter MG, et al. Survival in pediatric lung transplantation: The effect of center volume and expertise. J Heart Lung Transplant. 2015;34(8):1073–81.
Waseda R, Benazzo A, Hoetzenecker K, Jaksch P, Murakozy G, Gruber S, et al. The influence of retransplantation on survival for pediatric lung transplant recipients. J Thorac Cardiovasc Surg. 2018;156(5):2025–34.
Hofer M, Benden C, Inci I, Schmid C, Irani S, Speich R, et al. True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. J Heart Lung Transplant. 2009;28(4):334–9.
Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med. 2007;357(21):2143–52.
Snell G, Reed A, Stern M, Hadjiliadis D. The evolution of lung transplantation for cystic fibrosis: A 2017 update. J Cyst Fibros. 2017;16(5):553–64.
Yeung JC, Machuca TN, Chaparro C, Cypel M, Stephenson AL, Solomon M, et al. Lung transplantation for cystic fibrosis. J Heart Lung Transplant. 2020;39(6):553–60.
Elizur A, Faro A, Huddleston CB, Gandhi SK, White D, Kuklinski CA, et al. Lung transplantation in infants and toddlers from 1990 to 2004 at St. Louis Children’s Hospital. Am J Transplant. 2009;9(4):719–26.
Sweet SC. Pediatric living donor lobar lung transplantation. Pediatr Transplant. 2006;10(7):861–8.
Woo MS, MacLaughlin EF, Horn MV, Szmuszkovicz JR, Barr ML, Starnes VA. Bronchiolitis obliterans is not the primary cause of death in pediatric living donor lobar lung transplant recipients. J Heart Lung Transplant. 2001;20(5):491–6.
Paraskeva MA, Edwards LB, Levvey B, Stehlik J, Goldfarb S, Yusen RD, et al. Outcomes of adolescent recipients after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant. 2018;37(3):323–31.
Sritippayawan S, Keens TG, Horn MV, MacLaughlin EF, Barr ML, Starnes VA, et al. Does lung growth occur when mature lobes are transplanted into children? Pediatr Transplant. 2002;6(6):500–4.
Choong CK, Sweet SC, Zoole JB, Guthrie TJ, Mendeloff EN, Haddad FJ, et al. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome. J Thorac Cardiovasc Surg. 2006;131(1):198–203.
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349(22):2117–27.
Sweet SC. Assessing the impact of program volume and composition on waiting list outcomes in pediatric lung transplantation. J Heart Lung Transplant. 2017;36(11):1180–2.
Sweet SC. Pediatric lung transplantation. Respir Care. 2017;62(6):776–98.
Funding
This work was supported by a Grant-in-Aid for Scientific Research (20K09176) from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest relevant to this article to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Otani, S., Yamamoto, H., Tanaka, S. et al. Paediatric lung transplantation: the impact of age on the survival. Surg Today 52, 1540–1550 (2022). https://doi.org/10.1007/s00595-022-02492-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-022-02492-w